跳至主要内容
临床试验/NCT00675246
NCT00675246已完成不适用

Antenatal Corticoid Therapy for Fetal Lung Maturation in Late Preterm Pregnancies: a Randomized Controlled Trial

Instituto Materno Infantil Prof. Fernando Figueira1 个研究点 分布在 1 个国家目标入组 320 人开始时间: 2008年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
320
试验地点
1
主要终点
neonatal respiratory distress

研究概览

简要总结

This study aims to determine the effectiveness of antenatal corticosteroid therapy in late preterm babies. The investigators hypothesis is corticoid accelerates fetal lung maturation even after 34 weeks and reduces risk of respiratory distress syndrome and other neonatal morbidities.

详细描述

Late preterm babies have important morbidity when compared with term babies, with oxygen requirement and more days of hospitalization. If antenatal corticosteroid therapy is necessary for fetal lung maturation after 34 weeks, it remains to be established. The systematic review with metanalysis in Cochrane Library includes a small number of late preterm babies and no conclusion about effectiveness of corticoid therapy in this setting could be drawn. Our hypothesis is that antenatal corticosteroid therapy is effective to prevent respiratory disease and morbidity in late preterm babies and this study will be carried out to evaluate this question.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 49 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Pregnancy between 34 and 36 weeks
  • Confirmed gestational age (LMP, USG)
  • Alive fetus
  • Imminent risk of preterm delivery

排除标准

  • Multiple pregnancy
  • Major fetal malformations
  • Comproved fetal lung maturity
  • Maternal or fetal indication for immediate interruption of pregnancy
  • Maternal hemorrhagic syndromes (placenta previa, abruptio placenta)
  • Chorioamnionitis
  • Chronic use of corticosteroids
  • Previous use of corticosteroids for fetal lung maturation in the current pregnancy

研究组 & 干预措施

A

Experimental

Antenatal corticoid therapy

干预措施: Betamethasone (Drug)

结局指标

主要结局

neonatal respiratory distress

时间窗: neonatal period (28 days of life)

次要结局

  • neonatal death(neonatal period (28 days of life))
  • during of neonatal hospitalization(neonatal period (28 days of life))
  • neonatal sepsis(neonatal period (28 days of life))
  • neonatal oxygen requirement(neonatal period (28 days of life))

研究者

发起方
Instituto Materno Infantil Prof. Fernando Figueira
申办方类型
Other

研究点 (1)

Loading locations...

相似试验